Corticosteroid-dependent, aldosterone-independent mineralocorticoid-receptor activation in the heart.

作者信息

van den Meiracker Anton H, Batenburg Wendy W

机构信息

Division of Pharmacology and Vascular and Metabolic Diseases, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.

出版信息

J Hypertens. 2008 Jul;26(7):1307-9. doi: 10.1097/HJH.0b013e328305e195.

DOI:10.1097/HJH.0b013e328305e195

PMID:18551003

Abstract

摘要

相似文献

Corticosteroid-dependent, aldosterone-independent mineralocorticoid-receptor activation in the heart.

J Hypertens. 2008 Jul;26(7):1307-9. doi: 10.1097/HJH.0b013e328305e195.

Nongenomic actions of aldosterone: physiological or pathophysiological role?

Steroids. 2006 Apr;71(4):277-80. doi: 10.1016/j.steroids.2005.09.017. Epub 2005 Nov 8.

Corticosteroid hormones in the central stress response: quick-and-slow.

Front Neuroendocrinol. 2008 May;29(2):268-72. doi: 10.1016/j.yfrne.2007.10.002. Epub 2007 Oct 24.

Mineralocorticoid receptor activation in obesity hypertension.

Hypertens Res. 2009 Aug;32(8):649-57. doi: 10.1038/hr.2009.86. Epub 2009 Jun 12.

[Mineralocorticoid receptor and its signal transduction].

Nihon Rinsho. 2005 Mar;63 Suppl 3:226-31.

Aldosterone and mineralocorticoid receptors: a personal reflection.

Mol Cell Endocrinol. 2012 Mar 24;350(2):146-50. doi: 10.1016/j.mce.2011.11.026. Epub 2011 Dec 3.

Molecular and cellular determinants of mineralocorticoid selectivity.

Curr Opin Nephrol Hypertens. 1999 Jan;8(1):45-51. doi: 10.1097/00041552-199901000-00008.

Is aldosterone bad for the heart?

Trends Endocrinol Metab. 2004 May-Jun;15(4):139-42. doi: 10.1016/j.tem.2004.03.006.

Current Opinion in Endocrinology, Diabetes & Obesity. Editorial overview.

Curr Opin Endocrinol Diabetes Obes. 2010 Jun;17(3):187. doi: 10.1097/MED.0b013e3283394ef4.

The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissues.

Clin Biochem. 2005 May;38(5):401-9. doi: 10.1016/j.clinbiochem.2004.11.009.

引用本文的文献

Impairment of Arterial Compliance in Cushing's Syndrome.

Eur Endocrinol. 2014 Aug;10(2):161-164. doi: 10.17925/EE.2014.10.02.161. Epub 2014 Aug 28.

The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.

J Hypertens. 2015 Jan;33(1):44-60. doi: 10.1097/HJH.0000000000000415.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Corticosteroid-dependent, aldosterone-independent mineralocorticoid-receptor activation in the heart.

J Hypertens. 2008 Jul;26(7):1307-9. doi: 10.1097/HJH.0b013e328305e195.

Nongenomic actions of aldosterone: physiological or pathophysiological role?

Steroids. 2006 Apr;71(4):277-80. doi: 10.1016/j.steroids.2005.09.017. Epub 2005 Nov 8.

Corticosteroid hormones in the central stress response: quick-and-slow.

Front Neuroendocrinol. 2008 May;29(2):268-72. doi: 10.1016/j.yfrne.2007.10.002. Epub 2007 Oct 24.

Mineralocorticoid receptor activation in obesity hypertension.

Hypertens Res. 2009 Aug;32(8):649-57. doi: 10.1038/hr.2009.86. Epub 2009 Jun 12.

[Mineralocorticoid receptor and its signal transduction].

Nihon Rinsho. 2005 Mar;63 Suppl 3:226-31.

Aldosterone and mineralocorticoid receptors: a personal reflection.

Mol Cell Endocrinol. 2012 Mar 24;350(2):146-50. doi: 10.1016/j.mce.2011.11.026. Epub 2011 Dec 3.

Molecular and cellular determinants of mineralocorticoid selectivity.

Curr Opin Nephrol Hypertens. 1999 Jan;8(1):45-51. doi: 10.1097/00041552-199901000-00008.

Is aldosterone bad for the heart?

Trends Endocrinol Metab. 2004 May-Jun;15(4):139-42. doi: 10.1016/j.tem.2004.03.006.

Current Opinion in Endocrinology, Diabetes & Obesity. Editorial overview.

Curr Opin Endocrinol Diabetes Obes. 2010 Jun;17(3):187. doi: 10.1097/MED.0b013e3283394ef4.

The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissues.

Clin Biochem. 2005 May;38(5):401-9. doi: 10.1016/j.clinbiochem.2004.11.009.

引用本文的文献

Impairment of Arterial Compliance in Cushing's Syndrome.

Eur Endocrinol. 2014 Aug;10(2):161-164. doi: 10.17925/EE.2014.10.02.161. Epub 2014 Aug 28.

The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.

J Hypertens. 2015 Jan;33(1):44-60. doi: 10.1097/HJH.0000000000000415.